Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04611464 · ClinicalTrials.gov registry record

Misoprostol for Spinal Stenosis

A clinical trial of Low Back Pain and Lumbar Spinal Stenosis, sponsored by Dallas VA Medical Center.

Completed
Registry status
23
Enrollment target
1
Study location

NCT04611464 is a study of Low Back Pain and Lumbar Spinal Stenosis that has completed, run by Dallas VA Medical Center. The registered enrollment target is 23 participants, below the 504-participant average among 122 other Low Back Pain trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04611464, a study of Low Back Pain and Lumbar Spinal Stenosis, has completed, sponsored by Dallas VA Medical Center.

COMPLETED
Registry status
23 participants
Enrollment target
1
Study location

Study Summary

This single-group cross-sectional cohort study will enroll approximately 25 patients at the North Texas VA Health Care System (VANTHCS) who have previously received off-label prescriptions of misoprostol for lumbar spinal stenosis for any duration and who are willing to provide verbal and informed consent. Patients will answer a questionnaire regarding pain and functional improvement especially in reference to misoprostol treatment. Patients will also be selected to have their walking tolerance (claudication distance) measured in an outpatient clinic setting to determine the severity of their lumbar spinal stenosis symptoms after having received misoprostol.

Interventions

  • DRUG Misoprostol

Study Locations (1)

Texas

  • Dallas VA Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2019-07-11
Est. Completion 2020-06-01

Sponsor

Dallas VA Medical Center

20 total trials

What the Registry Record Tells You About NCT04611464

The ClinicalTrials.gov registry entry for NCT04611464 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 504-participant average among 122 other Low Back Pain trials with a reported enrollment target (95% lower). The listed sponsor is Dallas VA Medical Center, which has 20 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Low Back Pain appearing as the primary indexed condition, and to 1 intervention - of which Misoprostol is the first listed.

NCT04611464 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT04611464 about?

NCT04611464 is a clinical study titled "Misoprostol for Spinal Stenosis". This single-group cross-sectional cohort study will enroll approximately 25 patients at the North Texas VA Health Care System (VANTHCS) who have previously received off-label prescriptions of misoprostol for lumbar spinal stenosis for any duration and who are willing to provide verbal and informed c...

What is the current status of trial NCT04611464?

This trial is currently completed. The enrollment target is 23 participants. The study started on 2019-07-11. Estimated completion is 2020-06-01.

What conditions does trial NCT04611464 study?

This clinical trial studies the following conditions: Low Back Pain, Lumbar Spinal Stenosis.

What interventions are being tested in trial NCT04611464?

The interventions under investigation include: Misoprostol (DRUG).

Who is sponsoring clinical trial NCT04611464?

This trial is sponsored by Dallas VA Medical Center, which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04611464 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Low Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.